澳股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Anagenics Ltd

0.006

0.000

成交量：7.50萬

成交額：450.00

市值：297.79萬

市盈率：-0.35

高：0.006

開：0.006

低：0.006

收：0.006

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Anagenics Ltd

交易所：

ASX

成立時間：

2004

員工人數：

- -

公司地址：

55 Clarence Street,Suite 204,Level 2,Sydney,New South Wales,Australia

官網：

http://www.cellmid.com.au

郵編：

2000

電話：

傳真：

61 2 9221 8535

簡介：

Cellmid Limited, a life sciences company, develops and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers Midkine (MK) ELISA Kit, a cancer biomarker, and diagnostic and prognostic tool. It is also developing CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. In addition, the company develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AN1.AU/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AN1.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AN1.AU\",,,,,undefined,":{"symbol":"AN1.AU","market":"AU","secType":"STK","nameCN":"Anagenics Ltd","latestPrice":0.006,"timestamp":1751868720000,"preClose":0.006,"halted":0,"volume":74972,"delay":0,"nameEN":"Anagenics Ltd","floatShares":130868958,"shares":496320360,"eps":-0.017142,"marketStatus":"未開盤","change":0,"latestTime":"07-07 16:12:00 AEST","open":0.006,"high":0.006,"low":0.006,"amount":450,"amplitude":0,"askPrice":0.007,"askSize":4250000,"bidPrice":0.006,"bidSize":6706,"shortable":3,"etf":0,"ttmEps":-0.017142,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1751932800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.006,"openAndCloseTimeList":[[1751846400000,1751868000000]],"volumeRatio":0.6780096336317157,"lotSize":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AN1.AU\",,,,,undefined,":{"symbol":"AN1.AU","floatShares":130868958,"roa":"-27.30%","roe":"-135.49%","lyrEps":-0.018781,"volumeRatio":0.6780096336317157,"shares":496320360,"dividePrice":0,"high":0.006,"amplitude":0,"preClose":0.006,"low":0.006,"week52Low":0.004,"pbRate":"1.32","psRate":"0.41","week52High":0.009,"institutionHeld":0,"latestPrice":0.006,"committee":-0.996849,"eps":-0.017142,"divideRate":0,"volume":74972,"delay":0,"ttmEps":-0.017142,"open":0.006,"prevYearClose":0.008,"prevWeekClose":0.006,"prevMonthClose":0.005,"prevQuarterClose":0.005,"fiveDayClose":0.005,"twentyDayClose":0.006,"sixtyDayClose":0.008},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":22744699,"yearFounded":2004,"address":"55 Clarence Street,Suite 204,Level 2,Sydney,New South Wales,Australia","zipCode":"2000","officePhone":"61 2 9221 6830","officeFax":"61 2 9221 8535"},"stockCompanyDetail":{"websiteUrl":"http://www.cellmid.com.au","stockEarnings":[{"period":"1week","weight":0.2},{"period":"1month","weight":0},{"period":"3month","weight":-0.25},{"period":"6month","weight":-0.25},{"period":"1year","weight":-0.25},{"period":"ytd","weight":-0.25}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.123},{"period":"6month","weight":0.1366},{"period":"1year","weight":0.2152},{"period":"ytd","weight":0.1479}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Cellmid Limited, a life sciences company, develops and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers Midkine (MK) ELISA Kit, a cancer biomarker, and diagnostic and prognostic tool. It is also developing CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. In addition, the company develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.005208},{"month":2,"riseRate":0.5,"avgChangeRate":0.034268},{"month":3,"riseRate":0,"avgChangeRate":-0.168242},{"month":4,"riseRate":0.25,"avgChangeRate":-0.176731},{"month":5,"riseRate":0.25,"avgChangeRate":-0.148485},{"month":6,"riseRate":0.75,"avgChangeRate":0.131282},{"month":7,"riseRate":0.666667,"avgChangeRate":0.066138},{"month":8,"riseRate":0.666667,"avgChangeRate":0.101425},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014493},{"month":10,"riseRate":0,"avgChangeRate":-0.126587},{"month":11,"riseRate":0,"avgChangeRate":-0.045977},{"month":12,"riseRate":0,"avgChangeRate":-0.095307}],"exchange":"ASX","name":"Anagenics Ltd","nameEN":"Anagenics Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AN1.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AN1.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AN1.AU\",market:\"AU\",,,undefined,":[]}}